AAAAAA
Results: 126-150/3357
Authors:
Kedzierski, L
Black, CG
Stowers, AW
Goschnick, MW
Kaslow, DC
Coppel, RL
Citation: L. Kedzierski et al., Comparison of the protective efficacy of yeast-derived and Escherichia coli-derived recombinant merozoite surface protein 4/5 against lethal challenge by Plasmodium yoelii, VACCINE, 19(32), 2001, pp. 4661-4668
Authors:
Le, TTT
Drane, D
Malliaros, J
Cox, JC
Rothel, L
Pearse, M
Woodberry, T
Gardner, J
Suhrbier, A
Citation: Ttt. Le et al., Cytotoxic T cell polyepitope vaccines delivered by ISCOMs, VACCINE, 19(32), 2001, pp. 4669-4675
Authors:
Clements-Mann, ML
Dudas, R
Hoshino, Y
Nehring, P
Sperber, E
Wagner, M
Stephens, I
Karron, R
Deforest, A
Kapikian, AZ
Citation: Ml. Clements-mann et al., Safety and immunogenicity of live attenuated quadrivalent human-bovine (UK) reassortant rotavirus vaccine administered with childhood vaccines to infants, VACCINE, 19(32), 2001, pp. 4676-4684
Authors:
Eo, SK
Lee, S
Kumaraguru, U
Rouse, BT
Citation: Sk. Eo et al., Immunopotentiation of DNA vaccine against herpes simplex virus via co-delivery of plasmid DNA expressing CCR7 ligands, VACCINE, 19(32), 2001, pp. 4685-4693
Authors:
Rothman, AL
Kanesa-thasan, N
West, K
Janus, J
Saluzzo, JF
Ennis, FA
Citation: Al. Rothman et al., Induction of T lymphocyte responses to dengue virus by a candidate tetravalent live attenuated dengue virus vaccine, VACCINE, 19(32), 2001, pp. 4694-4699
Authors:
Ronan, K
Wallace, MR
Citation: K. Ronan et Mr. Wallace, The utility of serologic testing for varicella in an adolescent population, VACCINE, 19(32), 2001, pp. 4700-4702
Authors:
Jackson, LA
Austin, G
Chen, RT
Stout, R
DeStefano, F
Gorse, GJ
Newman, FK
Yu, O
Weniger, BG
Citation: La. Jackson et al., Safety and immunogenicity of varying dosages of trivalent inactivated influenza vaccine administered by needle-free jet injectors, VACCINE, 19(32), 2001, pp. 4703-4709
Authors:
Joines, RW
Blatter, M
Abraham, B
Xie, F
De Clercq, N
Baine, Y
Reisinger, KS
Kuhnen, A
Citation: Rw. Joines et al., A prospective, randomized, comparative US trial of a combination hepatitisA and B vaccine (Twinrix (R)) with corresponding monovalent vaccines (Havrix (R) and Engerix-B (R)) in adults, VACCINE, 19(32), 2001, pp. 4710-4719
Authors:
Scheifele, DW
Halperin, SA
Ferguson, AC
Citation: Dw. Scheifele et al., Assessment of injection site reactions to an acellular pertussis-based combination vaccine, including novel use of skin tests with vaccine antigens, VACCINE, 19(32), 2001, pp. 4720-4726
Authors:
Hornick, R
Tucker, R
Kaplan, KM
Eves, KA
Banerjee, D
Jensen, E
Kuter, B
Citation: R. Hornick et al., A randomized study of a flexible booster dosing regimen of VAQTA (R) in adults: safety, tolerability, and immunogenicity, VACCINE, 19(32), 2001, pp. 4727-4731
Authors:
Eyles, JE
Bramwell, VW
Williamson, ED
Alpar, HO
Citation: Je. Eyles et al., Microsphere translocation and immunopotentiation in systemic tissues following intranasal administration, VACCINE, 19(32), 2001, pp. 4732-4742
Authors:
Cox, RJ
Mykkeltvedt, E
Sjursen, H
Haaheim, LR
Citation: Rj. Cox et al., The effect of zanamivir treatment on the early immune response to influenza vaccination, VACCINE, 19(32), 2001, pp. 4743-4749
Authors:
Zimmerman, DH
Lloyd, JP
Heisey, D
Winship, MD
Siwek, M
Talor, E
Sarin, PS
Citation: Dh. Zimmerman et al., Induction of cross clade reactive specific antibodies in mice by conjugates of HGP-30 (peptide analog of HIV-1(SF2) p17) and peptide segments of human beta-2-microglobulin or MHC II beta chain, VACCINE, 19(32), 2001, pp. 4750-4759
Authors:
Bovier, PA
Chamot, E
Gallacchi, MB
Loutan, L
Citation: Pa. Bovier et al., Importance of patients' perceptions and general practitioners' recommendations in understanding missed opportunities for immunisations in Swiss adults, VACCINE, 19(32), 2001, pp. 4760-4767
Authors:
Pitt, MLM
Little, SF
Ivins, BE
Fellows, P
Barth, J
Hewetson, J
Gibbs, P
Dertzbaugh, M
Friedlander, AM
Citation: Mlm. Pitt et al., In vitro correlate of immunity in a rabbit model of inhalational anthrax, VACCINE, 19(32), 2001, pp. 4768-4773
Authors:
Hayasaka, D
Goto, A
Yoshii, K
Mizutani, T
Kariwa, H
Takashima, I
Citation: D. Hayasaka et al., Evaluation of European tick-borne encephalitis virus vaccine against recent Siberian and far-eastern subtype strains, VACCINE, 19(32), 2001, pp. 4774-4779
Authors:
Cornu, C
Yzebe, D
Leophonte, P
Gaillat, J
Boissel, JP
Cucherat, M
Citation: C. Cornu et al., Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults:a meta-analysis of randomized trials, VACCINE, 19(32), 2001, pp. 4780-4790
Authors:
Gil, A
Oyaguez, I
Carrasco, P
Gonzalez, A
Citation: A. Gil et al., Hospital admissions for pertussis in Spain, 1995-1998, VACCINE, 19(32), 2001, pp. 4791-4794
Authors:
Lemaire, M
Schynts, F
Meyer, G
Georgin, JP
Baranowski, E
Gabriel, A
Ros, C
Belak, S
Thiry, E
Citation: M. Lemaire et al., Latency and reactivation of a glycoprotein E negative bovine herpesvirus type 1 vaccine: influence of virus load and effect of specific maternal antibodies, VACCINE, 19(32), 2001, pp. 4795-4804
Authors:
Blasco, E
Lambot, M
Barrat, J
Cliquet, F
Brochier, B
Renders, C
Krafft, N
Bailly, J
Munier, M
Pastoret, PP
Aubert, MFA
Citation: E. Blasco et al., Kinetics of humoral immune response after rabies VR-G oral vaccination of captive fox cubs (Vulpes vulpes) with or without maternally derived antibodies against the vaccine, VACCINE, 19(32), 2001, pp. 4805-4815
Authors:
Sinnathamby, G
Renukaradhya, GJ
Rajasekhar, M
Nayak, R
Shaila, MS
Citation: G. Sinnathamby et al., Immune responses in goats to recombinant hemagglutinin-neuraminidase glycoprotein of Peste des petits ruminants virus: identification of a T cell determinant, VACCINE, 19(32), 2001, pp. 4816-4823
Authors:
Nagai, T
Suzuki, Y
Kiyohara, H
Susa, E
Kato, T
Nagamine, T
Hagiwara, Y
Tamura, S
Yabe, T
Aizawa, C
Yamada, H
Citation: T. Nagai et al., Onjisaponins, from the root of Polygala tenuifolia Willdenow, as effectiveadjuvants for nasal influenza and diphtheria-pertussis-tetanus vaccines, VACCINE, 19(32), 2001, pp. 4824-4834
Authors:
Burgess, MA
Rodger, AJ
Waite, SA
Collard, F
Citation: Ma. Burgess et al., Comparative immunogenicity and safety of two dosing schedules of a combined hepatitis A and B vaccine in healthy adolescent volunteers: an open, randomised study, VACCINE, 19(32), 2001, pp. 4835-4841
Authors:
Rajeev, S
Kania, SA
Nair, RV
McPherson, JT
Moore, RN
Bemis, DA
Citation: S. Rajeev et al., Bordetella bronchiseptica fimbrial protein-enhanced immunogenicity of a Mannheimia haemolytica leukotoxin fragment, VACCINE, 19(32), 2001, pp. 4842-4850
Authors:
Schmidt, S
Zhu, DH
Barniak, V
Mason, K
Zhang, Y
Arumugham, R
Metcalf, T
Citation: S. Schmidt et al., Passive immunization with Neisseria meningitidis PorA specific immune serareduces nasopharyngeal colonization of group B meningococcus in an infant rat nasal challenge model, VACCINE, 19(32), 2001, pp. 4851-4858